Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Advertising system and method
Display panel and gate driving circuit and driving method for gate driving circuit
Lubricating oil compositions
Information distribution system, information distributing method, node, and recording medium
Tuning peg for a stringed instrument
Mobile advertising and compensation-verification system
Serving base station selection based on backhaul capability
  Randomly Featured Patents
Mounting structure of a multiple piston ring
Ethernet wide area network and method
Optical networking module including protocol processing and unified software control
Image display apparatus
Head retaining foam liner for car seat
Steamer with wrapped cord and hose
3-Amino-piperidine derivatives and methods of manufacture
Modular connector wiring system
Rapid efficient infrared curing powder/wet coatings and ultraviolet coatings curing laboratory applied production processing
Wide-view-angle and planarized-packing structure for IR heat sensing elements